Related Experiment Videos
[Serum ECP level of infants of atopic dermatitis]
H Nakato1, Y Wakazono, R Bessho
1Department of Pediatrics, Kansai-Denryoku Hospital.
Insights
Eosinophil cationic protein (ECP) levels in infant serum are significantly higher in those with atopic dermatitis (AD). Elevated ECP levels correlate with dermatitis severity, indicating its utility as a marker for AD in infants.
Area of Science:
- Pediatric dermatology
- Immunology
- Biomarker research
Context:
- Atopic dermatitis (AD) is a common inflammatory skin condition in infants.
- Early diagnosis and severity assessment of AD are crucial for effective management.
- Eosinophil cationic protein (ECP) is a mediator released by eosinophils.
Purpose:
- To investigate serum eosinophil cationic protein (ECP) levels in infants with atopic dermatitis (AD).
- To assess the correlation between ECP levels and the clinical severity of dermatitis in infants with AD.
- To determine if serum ECP is a reliable biomarker for AD severity in infants.
Summary:
- Serum ECP levels were measured in 47 infants with AD and compared to controls at multiple time points post-birth.
- Infants with AD exhibited significantly higher ECP levels than controls throughout the study period.
- A significant positive correlation was observed between serum ECP levels and the severity of dermatitis in infants with AD.
Impact:
- Serum ECP levels serve as a valuable and objective marker for assessing the severity of atopic dermatitis in infants.
- This finding can aid clinicians in monitoring disease progression and tailoring treatment strategies for pediatric AD.
- Further research may explore ECP's role in predicting AD outcomes and response to therapy.
Abstract:
Forty-seven infants with atopic dermatitis (AD) were examined for ECP (eosinophil cationic protein) levels in sera at 3 to 4, 6 to 7, 12 and 18 months after birth. ECP levels in AD were significantly higher than those of control infants at every examination. The levels of ECP in AD were significantly correlated with the severity of dermatitis judged by a slightly modified version of the method of Businco et al. We concluded that ECP levels in sera are a useful marker for the severity of dermatitis in infants with AD.